Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macias, R. I. R.
Right arrow Articles by Marin, J. J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macias, R. I. R.
Right arrow Articles by Marin, J. J. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Journal of Lipid Research, Vol. 39, 1792-1798, September 1998
Copyright © 1998 by Lipid Research, Inc.


Original Article

Transport and biotransformation of the new cytostatic complex cis-diammineplatinum(II)-chlorocholylglycinate (Bamet-R2) by the rat liver

Rocio I. R. Maciasa, Maria J. Montea, Mohamed Y. El-Mira, Gloria R. Villanuevaa, and Jose J. G. Marina
a Department of Physiology and Pharmacology, School of Pharmacy, University of Salamanca, Campus Miguel de Unamuno, E.D. S-09, 37007-Salamanca, Spain

Correspondence to: Jose J. G. Marin.

Rat liver uptake and bile output of the cytostatic complex cis -diammineplatinum(II)-chlorocholylglycinate (Bamet-R2) were studied. Up to 100 µM, Bamet-R2 uptake by rat hepatocytes in primary culture followed saturation kinetics (Vmax = 0.65 ± 0.12 nmol/5 min per mg protein; KM = 45.2 ± 10.7 µM). Bamet-R2 uptake was lower than that of cholylglycinate (CG) but higher than that of cisplatin. Replacement of 116 mM NaCl by 116 mM choline chloride did not significantly reduce Bamet-R2 uptake. Addition of 500 µM CG, cholic acid, estrone sulfate, or ouabain to 50 µM Bamet-R2-containing incubation media inhibited Bamet-R2 uptake. No liver biotransformation of Bamet-R2 occurred, as indicated by HPLC analysis of bile collected from anesthetized rats after intravenous administration of the drug. Bamet-R2 uptake and secretion into bile by isolated rat livers exceeded those of cisplatin but were lower than those of CG. Differences between Bamet-R2 and CG were more marked for bile output than for liver uptake. Thus, higher Bamet-R2 than CG or cisplatin liver content was found. Co-administration of Bamet-R2 and CG revealed that CG induced a slight reduction in Bamet-R2 uptake and a marked inhibition in Bamet-R2 bile output. By contrast, Bamet-R2 had no effect on CG on either liver uptake or bile output.

In sum, the present data indicate that Bamet-R2 is efficiently taken up and secreted into bile by the rat liver by mechanisms shared in part by natural bile acids.—Macias, R. I. R., M. J. Monte, M. Y. El-Mir, G. R. Villanueva, and J. J. G. Marin. Transport and biotransformation of the new cytostatic complex cis -diammineplatinum(II)-chlorocholylglycinate (Bamet-R2) by the rat liver. J. Lipid Res. 1998. 39: 1792–1798.

Supplementary key words: bile acid, cancer, chemotherapy, cisplatin, glycocholate, metal, platinum (Pt)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Monte, M. R. Ballestero, O. Briz, M. J. Perez, and J. J. G. Marin
Proapoptotic Effect on Normal and Tumor Intestinal Cells of Cytostatic Drugs with Enterohepatic Organotropism
J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 24 - 35.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
O. Briz, R. I. R. Macias, M. Vallejo, A. Silva, M. A. Serrano, and J. J. G. Marin
Usefulness of Liposomes Loaded with Cytostatic Bile Acid Derivatives to Circumvent Chemotherapy Resistance of Enterohepatic Tumors
Mol. Pharmacol., March 1, 2003; 63(3): 742 - 750.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
O. Briz, M. A. Serrano, N. Rebollo, B. Hagenbuch, P. J. Meier, H. Koepsell, and J. J.G. Marin
Carriers Involved in Targeting the Cytostatic Bile Acid-Cisplatin Derivatives cis-Diammine-chloro-cholylglycinate-platinum(II) and cis-Diammine-bisursodeoxycholate-platinum(II) toward Liver Cells
Mol. Pharmacol., April 1, 2002; 61(4): 853 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. F. Dominguez, R. I. R. Macias, I. Izco-Basurko, A. de la Fuente, M. J. Pascual, J. M. Criado, M. J. Monte, J. Yajeya, and J. J. G. Marin
Low in Vivo Toxicity of a Novel Cisplatin-Ursodeoxycholic Derivative (Bamet-UD2) with Enhanced Cytostatic Activity versus Liver Tumors
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1106 - 1112.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement